Healthcare innovation and marketing expert to help drive adoption of Welldoc’s platform serving those with diabetes, prediabetes, hypertension, heart failure and behavioral health needs
Columbia, MD – March 10, 2021 – Welldoc®, a trailblazer in digital health that is revolutionizing chronic condition management to help transform lives, today announced the appointment of Marina Dorotheo to the position of chief marketing officer. In this role, Marina will lead Welldoc’s strategic marketing as the company enters its next phase of growth.
“I am pleased to welcome Marina Dorotheo to Welldoc,” said Keith Reynolds, chief operating officer at Welldoc. “Her expertise in both digital health innovation and healthcare marketing will be invaluable for the company as we continue to grow our operations, and I look forward to her joining our team.”
Prior to joining Welldoc, Marina spent 22 years at Otsuka, where she accumulated a broad understanding of the healthcare ecosystem, health analytics and digital health. Marina led health innovation initiatives at Otsuka for the last eight years. Most recently, Marina served as the head of commercial strategy and marketing within Otsuka’s Digital Medicine hub.
“I am thrilled to join Welldoc, an innovator in the now diverse digital health field,” said Marina. “The company’s passion for creating data-driven tools for consumers and patients to support their health goals has altered the healthcare landscape, and I am honored to help drive this next phase of Welldoc’s journey.”
Welldoc’s platform combines a holistic approach with an evidence-based care model tailored to specific chronic conditions including diabetes, hypertension, behavioral health and more. Welldoc’s award-winning digital health solution for diabetes is backed by eight 510(k)s and includes a comprehensive platform with education, real-time feedback and an Insulin Adjustment program. The platform is device agnostic, allowing for seamless integration with a patient’s existing blood glucose meters, pharmacies, labs, and activity and fitness trackers.
Welldoc® is revolutionizing chronic condition management to help transform lives. BlueStar®, an FDA-cleared digital health solution, guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their conditions and enhancing connections to their healthcare team. Welldoc streamlines the relationships between payers, employers and healthcare systems resources, with the goal of improving population health and reducing costs of chronic care. For more information, visit www.welldoc.com.